Nuheara (ASX:NUH) - 주가, 뉴스 및 분석

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

NUH 주식 개요

A wearables technology company, engages in the development and commercialization of hearing technology and products as regulated medical devices in Australia, the United States, and internationally.

회사 소개

NUH 기본 분석
눈송이 점수
가치 평가	0/6
미래 성장	0/6
과거 실적	0/6
재무 상태	3/6
배당금	0/6

보상

위험 분석

지난 5년간 매년 수익이 11.8% 씩 감소했습니다.

지난 1년 동안 주주가 크게 희석되었습니다.

주식은 유동성이 매우 낮습니다

최신 재무 보고서가 6개월 이상 지났습니다.

+ 2 더 많은 위험

Nuheara Limited 경쟁사

BirdDog Technology

ASX:BDT

AU$14.9m

Zimi

ASX:ZMM

AU$1.4m

Ava Risk Group

ASX:AVA

AU$30.1m

Senetas

ASX:SEN

AU$20.4m

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Nuheara
과거 주가
현재 주가	AU$0.081
52주 최고치	AU$0.21
52주 최저치	AU$0.07
베타	1.87
11개월 변경	0%
3개월 변경 사항	3.85%
1년 변경 사항	-42.14%
33년 변화	-90.36%
5년 변화	-94.53%
IPO 이후 변화	-91.38%

최근 뉴스 및 업데이트

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Oct 09

Recent updates

주주 수익률

	NUH	AU Tech	AU 마켓
7D	0%	0.8%	-0.3%
1Y	-42.1%	12.5%	8.3%

수익률 대 산업: NUH 지난 1년 동안 19.1 %를 반환한 Australian Tech 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: NUH 지난 1년 동안 6.7 %를 반환한 Australian 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is NUH's price volatile compared to industry and market?
NUH volatility
NUH Average Weekly Movement	n/a
Tech Industry Average Movement	5.9%
Market Average Movement	8.2%
10% most volatile stocks in AU Market	16.3%
10% least volatile stocks in AU Market	3.2%

안정적인 주가: NUH 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: 지난 1년간 NUH 의 변동성 변화를 확인하기에는 데이터가 충분하지 않습니다.

회사 소개

설립	직원	CEO	웹사이트
n/a	n/a	Justin Miller	www.nuheara.com

Nuheara Limited 기본 사항 요약

Nuheara 의 수익과 매출은 시가총액과 어떻게 비교하나요?
NUH 기본 통계
시가총액	AU$21.76m
수익(TTM)	-AU$12.62m
수익(TTM)	AU$1.93m

11.3x

P/S 비율

-1.7x

P/E 비율

NUH 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
NUH 손익 계산서(TTM)
수익	AU$1.93m
수익 비용	AU$2.88m
총 이익	-AU$951.47k
기타 비용	AU$11.67m
수익	-AU$12.62m

최근 보고된 수익

Jun 30, 2023

다음 수익 날짜

n/a

주당 순이익(EPS)	-0.047
총 마진	-49.27%
순이익 마진	-653.33%
부채/자본 비율	46.3%

NUH 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

NUH 주식 개요

보상

위험 분석

Nuheara Limited 경쟁사

ASX:BDT

AU$14.9m

ASX:ZMM

AU$1.4m

ASX:AVA

AU$30.1m

ASX:SEN

AU$20.4m

가격 내역 및 성능

최근 뉴스 및 업데이트

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 1.850332 million.

Nuheara Limited Announces the Retirement of David Cannington as Non-Executive Director

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.929624 million.

New major risk - Shareholder dilution

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Full year 2023 earnings released: AU$0.084 loss per share (vs AU$0.16 loss in FY 2022)

Recent updates

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 1.850332 million.

Nuheara Limited Announces the Retirement of David Cannington as Non-Executive Director

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.929624 million.

New major risk - Shareholder dilution

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Full year 2023 earnings released: AU$0.084 loss per share (vs AU$0.16 loss in FY 2022)

Nuheara Limited, Annual General Meeting, Nov 22, 2023

New major risk - Financial position

Nuheara Limited Announces Appointment of Catherine Morgan as Head of Compliance, Regulatory and Legal

New minor risk - Share price stability

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 4.4 million.

First half 2023 earnings released: AU$0.048 loss per share (vs AU$0.065 loss in 1H 2022)

Insufficient new directors

Nuheara Announces Commercial Availability of HP Hearing PRO OTC Hearing Aid

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.025401 million.

Nuheara Limited Receives US FDA Approval and Launches HP Hearing PRO

Nuheara Limited to Report Q1, 2023 Results on Oct 31, 2022

Nuheara Limited Announces the Resignation of Jean-Marie Rudd as CFO

Full year 2022 earnings released: AU$0.16 loss per share (vs AU$0.10 loss in FY 2021)

Nuheara Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.093 loss in FY 2021)

Nuheara Limited Welcomes US Food and Drug Administration's Final Ruling, Establishing A Regulatory Category for Over-The-Counter (Otc) Hearing Aids in the United States

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Nuheara Limited Announces Executive Changes

Nuheara Limited has filed an IPO in the amount of AUD 5 million.

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Nuheara Submits 510(k) for U.S. FDA Clearance

Nuheara Announces Executive Changes

Nuheara Limited Announces Successful Clinical Trial Self-Fitted Hearing Aids

Nuheara Limited to Report Q2, 2022 Results on Jan 31, 2022

Nuheara Clinical Trial and FDA 510(K) Pathway Update

We Think Nuheara (ASX:NUH) Needs To Drive Business Growth Carefully

Nuheara Limited Provides Update on Clinical Trial and Pathway to FDA 510(K) Approval

Is Nuheara (ASX:NUH) In A Good Position To Deliver On Growth Plans?

Full year 2021 earnings released: AU$0.005 loss per share (vs AU$0.011 loss in FY 2020)

Nuheara Limited Receives U.S. FDA Registration and Hearing Aid Device Listing

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.006 loss in 1H 2020)

What Can We Make Of Nuheara's (ASX:NUH) CEO Compensation?

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 11.5 million.

Nuheara Limited announced that it expects to receive AUD 11.5 million in funding

Nuheara Limited Appoints Warwick Sauer as Director

Is Nuheara (ASX:NUH) Using Debt In A Risky Way?

Nuheara Receives $2 Million Phase II Works with HP Inc

Full year earnings released - AU$0.011 loss per share

Nuheara Limited announced that it has received funding

주주 수익률

가격 변동성

회사 소개

Nuheara Limited 기본 사항 요약

11.3x

-1.7x

수익 및 수익